Baird Medical Investment Holdings Ltd BDMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
-
Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion
-
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
Trading Information
- Previous Close Price
- $1.13
- Day Range
- $1.13–1.19
- 52-Week Range
- $0.76–3.75
- Bid/Ask
- $1.13 / $1.15
- Shares Outstanding
- 31.98M
- Market Cap
- $36.14M
- Volume/Avg
- 15,850 / 158,920
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.41
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 146
- Website
- —
Valuation
|
Metric
|
BDMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.12 |
Price/Sales | 1.41 |
Price/Cash Flow | — |
Price/Earnings
BDMD
Financial Strength
|
Metric
|
BDMD
|
|---|---|
Quick Ratio | 1.32 |
Current Ratio | 1.70 |
Interest Coverage | −34.77 |
Quick Ratio
BDMD
Profitability
|
Metric
|
BDMD
|
|---|---|
Return on Assets (Normalized) | −13.45% |
Return on Equity (Normalized) | −28.34% |
Return on Invested Capital (Normalized) | −16.53% |
Return on Assets
BDMD
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|N$>!<N% | LOCK|?Bd% | $164B | |||
| Stryker Corp
SYK
| LOCK|#<@@tz@? | LOCK|%PF | $126B | |||
| Medtronic PLC
MDT
| LOCK|&^B!P@F | LOCK|v^>Q | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|pg$&sV | LOCK|bGSvS | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%%vXRM$ | LOCK|%ST!! | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^XXsj!^ | LOCK|X$ | $29B | |||
| DexCom Inc
DXCM
| LOCK|#XMsFd< | LOCK|<w?z? | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|$H | LOCK|$X | $27B | |||
| Steris PLC
STE
| LOCK|#&#n<@ | LOCK|Dh&K^ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|wlKds^n^ | LOCK|dD | $18B |
United States